CAR T-cell therapy is one of the most talked-about emerging treatments in autoimmune disease — and people with MS are paying attention. Here’s what it is, why it matters, and what the early research really means for us.

There’s a wave of optimism building in the MS community. Tolebrutinib—a once-daily oral Bruton’s tyrosine kinase inhibitor (BTKi)—has...

On March 14, Congress passed a stopgap spending bill for the rest of the 2025 fiscal year. While that might not sound like a big deal on...

One of the most frustrating aspects of multiple sclerosis (MS) is the damage it causes to myelin, the protective coating around nerve...

A groundbreaking study from the University of Edinburgh demonstrates that genetically edited human stem cells could help repair myelin in...